To evaluate effects of intravitreal ranibizumab and bevacizumab administration on ambulatory blood pressure monitoring (ABPM) recordings in normotensive patients with age-related macular degeneration ...

Purpose: To review the literature regarding ocular hypertension following intravitreal antivascular endothelial growth factor therapy, and to propose a novel mechanism for the development of ocular ...

Following a request for judicial review by drugmakers Bayer and Novartis, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) issued a statement clarifying that Roche's Avastin ...

Three modalities have a role in the primary management of diabetic macular edema (DME): laser photocoagulation, intravitreal vascular endothelial growth factor (VEGF) inhibitors, and intravitreal ...

Please provide your email address to receive an email when new articles are posted on . PARIS — Macular edema due to branch retinal vein occlusion or central retinal vein occlusion can be effectively ...

STOCKHOLM -- Two VEGF-targeting gene therapies for neovascular age-related macular degeneration (nAMD) substantially reduced treatment burden while preserving visual acuity, according to results ...

Please provide your email address to receive an email when new articles are posted on . In the past decade, intravitreal injections have transformed the way that we treat retinal disease, particularly ...

According to Aldeyra Therapeutics, a phase 2/3 trial of ADX-2191 in patients with retinitis pigmentosa is expected to begin in 2025. The Food and Drug Administration (FDA) has granted Fast Track ...